Additionally, we selected TSPAN4 with the best prognostic performance for experimental validation and demonstrated that the proliferation, invasion, and migration of glioma cells were significantly inhibited after TSPAN4 knockdown. This evidence concerns the gene TSPAN4 and glioma.